{
  "meta": {
    "title": "Hematology",
    "url": "https://brainandscalpel.vercel.app/hematology-f5b5f9c7.html",
    "scrapedAt": "2025-11-30T11:19:50.419Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Argatroban</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Protamine</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old man undergoes surgery for a mitral valve replacement. Five days later, he develops non-blanching, darkened and purpuric lesions on his trunk and arms. Laboratory studies show a WBC count of 11,000/mL, an Hb level of 14 mg/dL, and a platelet count of 70,000/mL. Administration of which of the following drugs is most appropriate for this patient?</span></p>",
      "unique_key": "DT1191474",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191474,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This patient was most likely given <strong>heparin. </strong></li>\n<li>The complication described is <strong>heparin-induced thrombocytopenia (HIT)</strong>, caused by an <strong>IgG autoantibody </strong>that reacts with <strong>platelet factor 4 (PF4) </strong>on the platelet surface, forming a complex with heparin that leads to platelet activation and thrombosis.</li>\n<li>Heparin should be stopped immediately, and the patient switched to a<strong> direct thrombin inhibitor</strong>, such as argatroban or bivalirudin, or the selective factor Xa inhibitor, fondaparinux.</li>\n<li>There are two types of HIT:\n<ul>\n<li><strong>Type 1 </strong>is a nonimmune response that begins 1-2 days after heparin initiation, occurs in approximately 10-20% of heparin recipients, and causes mild to moderate thrombocytopenia (platelet count rarely &lt;100,000/mL). It is not associated with thrombosis.</li>\n<li><strong>Type 2 (HITT)</strong> is immune-mediated, uncommon but serious, occurring 4-14 days after heparin initiation. HITT is characterised by thrombocytopenia, thrombosis, and thromboembolic complications, which may rarely include severe manifestations such as skin necrosis or gangrene.</li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old woman with a history of ischemic stroke presents with chest pain and diaphoresis. ECG shows atrial fibrillation. After treatment is instituted, the patient no longer has chest pain, and troponin is normal. Which of the following drugs is most appropriate for this patient after stabilisation?</span></p>",
      "unique_key": "DT1191479",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191479,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The patient has <strong>atrial fibrillation (AF)</strong> and requires rate control, rhythm management, and anticoagulation after stabilisation.</li>\n<li>Given her age (&gt;75 years) and history of ischemic stroke, she has a <strong>high stroke risk</strong> per the <strong>CHA2DS2-VASc score</strong>.</li>\n<li><strong>Anticoagulation</strong> is essential to prevent clot formation in the fibrillating atrium, reducing the risk of stroke or systemic embolism.</li>\n<li><strong>Warfarin</strong>, which inhibits vitamin K-dependent coagulation factors (II, VII, IX, X, and proteins C and S), is appropriate for long-term anticoagulation in AF.</li>\n<li><strong>Heparin </strong>is typically used initially alongside warfarin until a therapeutic INR (2.0-3.0) is achieved, usually after 4-5 days, at which point heparin is discontinued.</li>\n<li>In modern practice, <strong>direct oral anticoagulants (DOACs) </strong>like apixaban or rivaroxaban may be preferred for non-valvular AF due to predictable dosing and no need for INR monitoring, but warfarin remains a valid option, especially if DOACs are contraindicated.</li>\n</ul>\n<p><strong>Explanation of other options</strong>:</p>\n<ul>\n<li><strong>Aspirin (Option A)</strong>: Insufficient for high-risk AF patients like this one with advanced age and prior stroke; warfarin or DOACs are preferred for stroke prevention.</li>\n<li><strong>Morphine (Option B)</strong>: Used for acute pain relief, not indicated here as chest pain has resolved and troponin is normal.</li>\n<li><strong>Propylthiouracil (Option C)</strong>: Treats hyperthyroidism, irrelevant as no hyperthyroidism is indicated.</li>\n</ul>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Aminocaproic acid</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Argatroban</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Reteplase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man is brought 2 h after the onset of severe chest pain. He has a history of poorly controlled mild hypertension and elevated blood cholesterol, but does not smoke. ECG changes of ST elevation and cardiac enzymes confirm the diagnosis of myocardial infarction. The decision is made to attempt to open his occluded artery. Which of the following drugs accelerates the conversion of plasminogen to plasmin?</span></p>",
      "unique_key": "DT1191482",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191482,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Reteplase</strong><strong>,</strong> a thrombolytic, accelerates the conversion of plasminogen to plasmin, promoting clot lysis in acute myocardial infarction (MI).</li>\n<li><strong>Heparin</strong> (anticoagulant), <strong>argatroban</strong> (direct thrombin inhibitor), and <strong>aminocaproic acid</strong> (plasminogen activation inhibitor) do not have this mechanism.</li>\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischemic stroke within the past 3 months</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Intracranial malignancy</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Current SBP > 180 mm Hg or DBP > 110 mm Hg</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Suspected aortic dissection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">If a fibrinolytic drug is used for the treatment of acute myocardial infarction, which of the following is not an absolute contraindication?</span></p>",
      "unique_key": "DT1191494",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191494,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Current SBP &gt;180 mm Hg or DBP &gt;110 mm Hg </strong>is a <strong>relative contraindication</strong>, as it can often be managed with antihypertensive therapy to allow fibrinolysis.</p>\n<p>Common contraindications for fibrinolysis in STEMI and STEMI-equivalents</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307898c0900-6f49-4088-8d29-aca92625d190.jpg\">",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Activated partial thromboplastin time</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleeding time</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor 2a levels</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin time</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old man presents with a sudden onset of shortness of breath and tachycardia. A spiral CT scan of the chest shows a pulmonary embolism. Treatment with a medication that causes an almost immediate inactivation of factor lla is begun. Which of the following laboratory studies will most likely be used to monitor the effect of the drug administered to this patient?</span></p>",
      "unique_key": "DT1191497",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Heparin</strong>, an anticoagulant, accelerates the activity of antithrombin III (ATIII), thereby inactivating thrombin (factor IIa) and factor Xa almost instantaneously.</li>\n<li>The <strong>heparin-ATIII complex</strong> can also inactivate factors IX, XI, XII, and plasmin.</li>\n<li>Heparin prevents the progression of existing clots by inhibiting further clotting, but does not directly cause lysis of existing clots, which relies on endogenous thrombolytic mechanisms.</li>\n<li>Heparin is often administered for <strong>acute pulmonary embolism or thrombosis</strong> by continuous IV infusion to achieve a therapeutic activated partial thromboplastin time (aPTT) range of approximately 1.5-2.5 times the control value.</li>\n<li>The <strong>aPTT</strong> measures the intrinsic system and common pathway, affected by factors I (fibrinogen), II (prothrombin), V, VIII, IX, X, XI, and XII.</li>\n<li>The anticoagulant effect of heparin should be monitored to ensure the aPTT remains within the therapeutic range of <strong>5-2.5</strong> times the control value.</li>\n<li>If the aPTT exceeds this range, the risk of internal bleeding increases.</li>\n</ul>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalamin</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old pregnant woman is referred by her obstetrician for evaluation of anaemia. This woman has macrocytic anaemia, an increased serum concentration of transferrin, and a normal serum concentration of vitamin B12. The most likely cause of her anaemia is deficiency of which of the following?</span></p>",
      "unique_key": "DT1191501",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Deficiencies of folic acid or vitamin B12 are the most common causes of megaloblastic anaemia. If a patient with this type of anaemia has a normal serum vitamin B12 concentration, folate deficiency is the most likely cause of the anaemia.</li>\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet count only</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Prothrombin time (PT) only</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Partial thromboplastin time (PTT) only</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">PT and PTT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old man presents with shortness of breath and chest pain. Coronary angiography shows a thrombotic occlusion of the left circumflex coronary artery. Treatment with a thrombolytic drug is begun. Which of the following measurements is most likely to be affected by this drug?</span></p>",
      "unique_key": "DT1191507",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191507,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Thrombosis </strong>can lead to acute myocardial injury, and thrombolytic agents like <strong>alteplase</strong> (a recombinant tissue plasminogen activator) are used to treat ST-elevation myocardial infarction (STEMI).</li>\n<li><strong>Alteplase</strong> binds to fibrin in a thrombus, converting entrapped plasminogen to plasmin, which degrades fibrin clots, resulting in <strong>fibrinolysis</strong>.</li>\n<li>This process increases fibrin degradation products (e.g., D-dimer) and may deplete fibrinogen, leading to <strong>prolonged prothrombin time (PT)</strong> and <strong>partial thromboplastin time (PTT).</strong></li>\n<li>Both PT and PTT can be affected due to<strong> reduced fibrinogen levels</strong> and interference with the coagulation cascade, though D-dimer is a more specific marker of thrombolytic activity.</li>\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyanocobalamin</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim (G-CSF)</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin (IL-11)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most likely to be required by a 5-year-old boy with chronic renal insufficiency?</span></p>",
      "unique_key": "DT1191510",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191510,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The kidney produces erythropoietin; patients with chronic renal insufficiency often require exogenous erythropoietin to avoid chronic anaemia.</li>\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim (G-CSF)</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrinsic factor</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin (interleukin-11)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old woman had a relapse of breast cancer. The cancer was now unresponsive to the standard doses of chemotherapy. A decision was made to treat the patient with high-dose chemotherapy followed by autologous stem cell transplantation. Which of the following drugs is needed for the patient's autologous stem cell transplantation?</span></p>",
      "unique_key": "DT1191514",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191514,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The success of transplantation with peripheral blood stem cells depends on the infusion of adequate numbers of hematopoietic stem cells.</li>\n<li>Administration of <strong>G-CSF </strong>to the donor (in the case of autologous transplantation, the patient who also will be the recipient of the transplantation) greatly increases the number of hematopoietic stem cells harvested from the donor's blood.</li>\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Alteplase</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticosteroids</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 69-year-old man with a history of well-controlled hypertension, atrial fibrillation, and type 2 diabetes is brought in because of decreased responsiveness. He appeared normal 2 hours before. Neurologic examination shows rightward deviation of his gaze and head posture and severe dysarthria with prominent left facial droop. Strength is 2/5 in the left upper and lower extremities. Reflexes are preserved throughout, as are flexor plantar responses. CT scan of the head shows no haemorrhage, but MRI of the brain shows ischemic injury to the right cerebral cortex. Which of the following is the most appropriate pharmacotherapy?</span></p>",
      "unique_key": "DT1191517",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191517,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Ischemic stroke is one of the leading causes of morbidity and mortality. It is considered a clinical emergency, and timely diagnosis and treatment can improve the patient's outcome.</li>\n<li>When a stroke is suspected, emergent brain imaging is essential to confirm the diagnosis of ischemic stroke before thrombolytics can be administered.</li>\n<li>Noncontrast computed tomography (CT) scanning is the most commonly used form of neuroimaging to evaluate a patient suspected of having an acute stroke.</li>\n<li>This patient presents with <strong>acute ischemic stroke</strong> (right MCA territory) within 2 hours, confirmed by CT (no haemorrhage) and MRI (ischemic injury).</li>\n<li><strong>Alteplase</strong>, a tissue plasminogen activator, is indicated within 3-4.5 hours of symptom onset in eligible patients to lyse clots and restore cerebral blood flow. It binds fibrin in thrombi, converting plasminogen to plasmin for fibrinolysis.</li>\n</ul>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">A high-fibre diet</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferrous sulfate tablets</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid supplements</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxocobalamin injections</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The lab for your pregnant patient indicates microcytic anaemia. Optimal treatment of normocytic or mild microcytic anaemia associated with pregnancy uses which of the following?</span></p>",
      "unique_key": "DT1191519",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191519,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Iron deficiency microcytic anaemia is the anaemia that is most commonly associated with In this condition, oral iron supplementation is indicated.</li>\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Dizziness, hypertension, and cerebral haemorrhage</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthermia, delirium, and coma</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Necrotising gastroenteritis, shock, and metabolic acidosis</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe hepatic injury, encephalitis, and coma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old pregnant woman who has a young child at home and is taking iron-containing prenatal supplements should be warned that they are a common source of accidental poisoning in young children. Toxicity associated with acute iron poisoning usually includes which of the following?</span></p>",
      "unique_key": "DT1191521",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191521,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Acute iron poisoning often causes severe gastrointestinal damage resulting from direct corrosive effects, <strong>shock from fluid loss in the gastrointestinal tract, and metabolic acidosis from cellular dysfunction.</strong></li>\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel directly binds to the platelet ADP receptors</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel facilitates the action of antithrombin III</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">The active metabolite of clopidogrel binds to and inhibits the platelet ADP receptors</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">The active metabolite of clopidogrel binds to and inhibits the platelet glycoprotein IIb/IIIa receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following most accurately describes the mechanism of action of clopidogrel?</span></p>",
      "unique_key": "DT1191524",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191524,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Clopidogrel</strong> is a prodrug activated by the <strong>CYP2C19 enzyme</strong> in the liver.</li>\n<li>Its <strong>active metabolite irreversibly</strong> binds to the P2Y12 component of ADP receptors on the platelet surface, <strong>inhibiting platelet aggregation </strong>and reducing the risk of thrombus formation.</li>\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Activated charcoal</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral deferasirox</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral deferoxamine</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Parenteral dantrolene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old child ingests the iron-containing supplements. What immediate treatment is necessary?</span></p>",
      "unique_key": "DT1191526",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191526,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Activated charcoal does not bind iron and thus is ineffective.</li>\n<li>Oral deferasirox is effective for <strong>chronic iron toxicity.</strong></li>\n<li>Dantrolene inhibits Ca2+ release from the sarcoplasmic reticulum and is an antidote for malignant hyperthermia induced by inhaled anaesthetics.</li>\n</ul>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Cancer recurrence</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Excessive bleeding</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxia</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67-year-old woman has been put on filgrastim after being treated with anticancer drugs. The therapeutic objective is to prevent which of the following?</span></p>",
      "unique_key": "DT1191528",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191528,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Filgrastim (G-CSF) stimulates the production and function of neutrophils, important cellular mediators of the innate immune system that serve as the first line of defence against infection.</li>\n</ul>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalamin</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">dTMP</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Homocysteine</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">N5-methyltetrahydrofolate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The megaloblastic anaemia that results from vitamin B12 deficiency is due to inadequate supplies of which of the following?</span></p>",
      "unique_key": "DT1191529",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191529,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Deficiency of vitamin B12 (cobalamin) leads to a deficiency in <strong>tetrahydrofolate </strong>and, subsequently, a deficiency of the <strong>dTMP </strong>required for DNA synthesis. Homocysteine and N5-methyltetrahydrofolate accumulate.</li>\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Darbepoetin alpha</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron dextran</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old woman with breast cancer is scheduled to receive 4 cycles of cancer chemotherapy. Her first cycle was complicated by severe chemotherapy-induced thrombocytopenia. During the second cycle of chemotherapy, it would be appropriate to consider treating this patient with which of the following?</span></p>",
      "unique_key": "DT1191530",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191530,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Oprelvekin (IL-11) </strong>stimulates<strong> platelet production </strong>and decreases the number of platelet transfusions required by patients undergoing bone marrow suppression therapy for cancer.</li>\n</ul>",
      "correct_choice_id": 164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin + Clopidogrel</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Abciximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old man undergoes a percutaneous coronary angiography procedure and placement of a stent in a coronary blood vessel. Appropriate pharmacological management will be?</span></p>",
      "unique_key": "DT1191532",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191532,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Dual antiplatelet therapy (DAPT)</strong> with <strong>aspirin</strong> and <strong>clopidogrel</strong> is the standard of care post-coronary stent placement to prevent stent thrombosis.</li>\n<li>DAPT is typically continued for <strong>6-12 months</strong> for drug-eluting stents, per current guidelines.</li>\n<li><strong>Clopidogrel</strong>, a prodrug, is activated by CYP2C19 in the liver, and its active metabolite irreversibly binds to the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation.</li>\n<li><strong>Aspirin </strong>inhibits cyclooxygenase-1 (COX-1), reducing thromboxane A2 production and further preventing platelet activation.</li>\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin + clopidogrel</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old woman with chronic hypertension and diabetes mellitus was recently admitted to the hospital for congestive heart failure and new-onset atrial fibrillation. An echocardiogram shows an ejection fraction of 40%; there are no valvular abnormalities. An ECG reveals only atrial fibrillation. What would be your next step in the pharmacological management?</span></p>",
      "unique_key": "DT1191536",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191536,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The patient's <strong>high stroke risk</strong>, calculated using the<strong> CHA2DS2-VASc score</strong> due to her age, hypertension, diabetes, and heart failure, indicates the need for <strong>anticoagulation </strong>rather than antiplatelet therapy. <strong>Warfarin </strong>is appropriate for long-term anticoagulation in atrial fibrillation to prevent stroke, with heparin used initially until a therapeutic INR (2.0-3.0) is achieved.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307225c9e88-6b3c-4c23-ab1d-7d8e18155924.jpg\">",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Abciximab</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Dabigatran</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Rivaroxaban</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Your consultants ask you to discuss the risks and benefits of anticoagulation therapy with the patient, including the option of using direct thrombin inhibitors. Which of the following anticoagulants is a direct inhibitor of thrombin?</span></p>",
      "unique_key": "DT1191537",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191537,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Dabigatran </strong>is a direct inhibitor of thrombin</li>\n<li><strong>Abciximab</strong> is an antiplatelet agent that binds to and inhibits GPIIb/IIIa.</li>\n<li><strong>Rivaroxaban</strong> is an oral factor X inhibitor.</li>\n<li><strong>Warfarin</strong> inhibits vitamin K epoxide reductase (VKOR).</li>\n</ul>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">X = intrinsic factor; Y = folic acid</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">X = intrinsic factor; Y = vitamin B12</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">X = extrinsic factor; Y = parenteral iron</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">X = extrinsic factor; Y = sargramostim</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male stomach cancer patient underwent surgery. After surgery, lab reports show Hb 7.8, MCH 28, MCV 120. His anaemia is caused by a deficiency of X and can be treated with Y.</span></p>",
      "unique_key": "DT1191540",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191540,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Resection of the stomach does lead to loss of<strong> intrinsic factor</strong><strong>,</strong> and the patient will be deficient in <strong>vitamin B12</strong>. Prevention or treatment of iron deficiency anaemia (microcytic cell size) is the only indication for iron administration. Sargramostim is a GM-CSF and is used to stimulate the production of neutrophils and other myeloid and megakaryocyte progenitors.</li>\n</ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Can be used without monitoring the patient's aPTT</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Has a shorter duration of action</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Is more likely to be given intravenously</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Is more likely to cause thrombosis and thrombocytopenia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 78-year-old woman presents with pain in her left thigh muscle. Doppler indicates the presence of DVT in the affected limb. The decision was made to treat this woman with enoxaparin. Relative to unfractionated heparin, enoxaparin:</span></p>",
      "unique_key": "DT1191543",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191543,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Enoxaparin's </strong>predictable pharmacokinetics and longer half-life allow for fixed subcutaneous dosing without routine aPTT monitoring, unlike <strong>unfractionated heparin</strong>, which requires aPTT monitoring to adjust dosing.</p>\n<ul>\n<li><strong>Enoxaparin</strong> is an LMW heparin. LMW heparins have a longer half-life than standard heparin and a more consistent relationship between dose and therapeutic effect.</li>\n<li>Enoxaparin is given subcutaneously, not intravenously. It is less, not more, likely to cause thrombosis and thrombocytopenia.</li>\n</ul>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Aminocaproic acid</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Protamine</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 82-year-old woman with DVT is started on warfarin. One month later, she returned after a severe nosebleed. Laboratory analysis revealed an INR of 7.0. To prevent severe haemorrhage, the warfarin should be discontinued, and this patient should be treated immediately with which of the following?</span></p>",
      "unique_key": "DT1191546",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191546,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The elevated INR indicates excessive anticoagulation with a high risk of haemorrhage.</li>\n<li>INR value in such a warfarin-treated patient should be 2.0-3.0.</li>\n<li>Warfarin should be discontinued and <strong>vitamin K1 </strong>administered to accelerate the formation of vitamin K-dependent factors.</li>\n</ul>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Alteplase</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man presents with severe chest pain, sweating, and nausea. Examination shows normal heart sounds and breath sounds. ECG shows sinus tachycardia with ST segment elevation in leads II, III, and aVF. After initial treatment, the chest pain decreases in intensity, and a reperfusion complex ventricular arrhythmia emerges. The arrhythmia is asymptomatic and resolves spontaneously. Which of the following drugs is most likely responsible for rapid reperfusion in this patient?</span></p>",
      "unique_key": "DT1191548",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This patient had an ST-elevation myocardial infarction (STEMI) and, following medical treatment, experienced symptomatic improvement and reperfusion-related arrhythmia; this is most likely the result of <strong>fibrinolytic (thrombolytic) therapy.</strong></li>\n<li>Fibrinolytic agents (e.g., <strong>alteplase</strong>) are indicated in patients with acute STEMI who cannot receive percutaneous coronary intervention promptly.</li>\n<li>Administration of these agents leads to breakdown of fibrin clot and often restoration of myocardial perfusion; some patients develop a self-limiting reperfusion-related arrhythmia (most commonly an accelerated idioventricular rhythm).</li>\n<li>In the fibrinolytic pathway, tissue plasminogen activator (PA) is released by the endothelium and cleaves plasminogen to form plasmin. Plasmin then acts to both degrade individual fibrinogen molecules and break down the fibrin clot that has already The breakdown of the fibrin clot leads to elevated levels of fibrin split products (eg, d-dimer) in the blood.</li>\n<li>Pharmacologic fibrinolytic agents that are used clinically include streptokinase and recombinant forms of tPA (e.g., <strong>alteplase</strong>, <strong>Tenecteplase</strong>).</li>\n<li>All of these agents inherently increase bleeding risk and are contraindicated in patients with increased risk of bleeding complications (e.g., recent hemorrhagic stroke).</li>\n</ul>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Apixaban</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Eptifibatide</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old man comes due to exertional chest pain over the last 6 months. He is a lifelong cigarette smoker and has a history of type 2 diabetes mellitus and peripheral artery disease. The patient undergoes treadmill exercise stress testing and develops substernal chest pain on moderate exertion accompanied by ECG changes that resolve immediately upon rest. The patient is started on low-dose aspirin therapy for secondary prevention of cardiovascular disease but experiences shortness of breath and wheezing with the medication. Which of the following is the best alternate therapy for this patient?</span></p>",
      "unique_key": "DT1191554",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191554,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This patient's clinical history is consistent with <strong>stable angina </strong>(angina pectoris) due to underlying coronary heart disease (CHD).</li>\n<li>Patients with stable angina should be started on <strong>aspirin </strong>to decrease the risk of adverse cardiovascular events.</li>\n<li>Aspirin impairs prostaglandin synthesis by irreversibly inhibiting cyclooxygenase (COX). Inhibition of COX-1 in platelets prevents synthesis of thromboxane A2, a potent stimulator of platelet aggregation and This helps reduce the risk of occlusive thrombus formation and subsequent myocardial infarction.</li>\n<li>Some patients are unable to tolerate aspirin due to exacerbation of pre-existing respiratory symptoms (e.g., rhinitis, asthma) or development of allergic reactions (e.g., urticaria, angioedema, anaphylaxis). In these patients, alternate antiplatelet agents should be used for the prevention of cardiovascular events.</li>\n<li><strong>Clopidogrel </strong>irreversibly blocks the <strong>P2Y 12 </strong>component of ADP receptors on the platelet surface and prevents platelet aggregation. Clopidogrel is as effective as aspirin for the prevention of cardiovascular events and should be used in patients with aspirin allergy.</li>\n</ul>",
      "correct_choice_id": 242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaphylaxis</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">Excess bleeding</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">Stroke</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 78-year-old woman does not want oral anticoagulation because she does not want to come to the clinic for frequent blood tests. You suggest an oral alternative and start her on apixaban and counsel her on the importance of taking the medication each day, as suddenly stopping can lead to:</span></p>",
      "unique_key": "DT1191556",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Due to the shorter half-life of the oral factor X and thrombin inhibitors, the anticoagulant status of the patient changes rapidly.</li>\n<li>Sudden cessation of apixaban, a direct factor Xa inhibitor with a short half-life, can lead to a rebound hypercoagulable state, increasing the risk of stroke, especially in patients with atrial fibrillation.</li>\n<li>Excess bleeding is associated with taking any of the anticoagulants, not with stopping them.</li>\n<li>An increase in INR reflects increased anticoagulation by warfarin. Thrombocytopenia is a risk associated with heparin.</li>\n</ul>",
      "correct_choice_id": 253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">aPTT</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor X assay</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">INR-PT test</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Factor-II test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man is started on rivaroxaban for his atrial fibrillation. Which of the following tests would provide accurate information about the coagulation status of a patient taking apixaban?</span></p>",
      "unique_key": "DT1191557",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191557,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>INR</strong> (measured as PT test) reflects changes due to warfarin and, to some extent, the thrombin inhibitors.</li>\n<li>Factor X inhibition is not reliably measured by the aPTT (used for unfractionated heparin) or PT test.</li>\n</ul>",
      "correct_choice_id": 262,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Dissection of the ascending aorta</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Intracerebral haemorrhage</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Myocardial reperfusion injury</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old man with a history of hypertension, type 2 diabetes, and asymptomatic carotid stenosis presents with severe mid-sternal chest pain and diaphoresis. His blood pressure is 120/70 mmHg, and pulse is 75/min. ECG shows ST elevation in leads II, III, and aVF. He is treated with aspirin, alteplase, a low-dose beta blocker, and a single dose of IV morphine. Several hours later, he becomes comatose with asymmetric pupils and irregular breathing. What is the most likely cause of his current condition?</span></p>",
      "unique_key": "DT1191560",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>This patient's presentation of chest pain, diaphoresis, and ECG findings of ST elevation in leads II, III, and aVF indicates an <strong>inferior ST-elevation myocardial infarction (STEMI). </strong></li>\n<li>Fibrinolytic therapy with <strong>alteplase </strong>was administered, as percutaneous coronary intervention (PCI) was likely unavailable.</li>\n<li><strong>Alteplase</strong>, a tissue plasminogen activator, binds fibrin in the thrombus, converting plasminogen to plasmin, which degrades the fibrin clot to restore coronary blood flow.</li>\n<li>However, fibrinolytics carry a significant risk of haemorrhage, particularly <strong>intracerebral haemorrhage (ICH)</strong>, especially in elderly patients (age &gt;75) or those with hypertension or other risk factors.</li>\n<li>The patient's subsequent coma, asymmetric pupils, and irregular breathing strongly suggest<strong> ICH </strong>as a complication of alteplase therapy.</li>\n</ul>",
      "correct_choice_id": 272,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolonged or traumatic CPR</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischemic stroke within the past 3 months</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Any prior intracranial bleeding</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Intracranial malignancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">If a fibrinolytic drug is used for the treatment of acute myocardial infarction, which of the following is NOT an absolute contraindication?</span></p>",
      "unique_key": "DT1191564",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Prolonged or traumatic CPR</strong> is a relative contraindication, not an absolute.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307eb16b591-dcb2-4be8-b62c-788f22494394.jpg\">",
      "correct_choice_id": 281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Clopidogrel</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Enoxaparin</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman with atrial fibrillation was prescribed medication to prevent stroke. She develops a lesion as shown in the photograph taken fourth and sixth days after the drug was begun, respectively. Which of the following drugs is most likely responsible for the findings seen in this patient?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240307c38d9b8d-af51-41ad-b099-ba7a514ea8e3.jpg\"></span></p>",
      "unique_key": "DT1191570",
      "question_audio": null,
      "question_video": null,
      "map_id": 1191570,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Warfarin, a coumarin anticoagulant, inhibits epoxide reductase, which blocks the ability to activate vitamin K.</li>\n<li>This prevents the vitamin K-dependent gamma-carboxylation of coagulation factors II, VII, IX, and X, thus inhibiting their synthesis.</li>\n<li>Warfarin similarly inhibits the vitamin-dependent synthesis of protein C and S, which have anticoagulant properties resulting from their inhibition of activated factors VIII and V.</li>\n<li>Because warfarin acts by inhibiting the synthesis of vitamin K-dependent factors, the factors affected first will be those with the shortest half-lives, which are protein C and factor VIIa.</li>\n<li>Thus, warfarin has an initial paradoxical procoagulant effect because of a rapid reduction in protein C, while activity of most of the endogenous clotting factors (vitamin-dependent factors within the common and intrinsic coagulation pathways, I, IX, and X) persists.</li>\n<li>This can lead to a state of hyper-coagulability and thrombosis. Warfarin may cause <strong>necrosis of the skin </strong>(typically on the breasts, buttocks, thighs, and abdomen), generally during the first several days of therapy.</li>\n<li>The lesions are initially sharply demarcated, erythematous, and purpuric. They may resolve or progress to large, irregular, hemorrhagic bullae that can eventually become necrotic.</li>\n<li>Patients receiving a large loading dose of warfarin or who have an existing protein C deficiency are most susceptible. Warfarin should be discontinued immediately, and heparin, vitamin K, and protein C should be used in therapy. Despite treatment, approximately 50% of patients will require skin grafting.</li>\n</ul>",
      "correct_choice_id": 294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}